Trials / Completed
CompletedNCT05309161
Efficacy Testing of Crassocephalum Rabens Extract Capsules
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Greenyn Biotechnology Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
This study is to investigate the improveing effects of the Crassocephalum rebens extract on skin conditions in normal people.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Crassocephalum rabens extract | dosage: a capsule (180 mg)/day; duration: 1 month |
Timeline
- Start date
- 2022-03-14
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
- First posted
- 2022-04-04
- Last updated
- 2022-08-03
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT05309161. Inclusion in this directory is not an endorsement.